Claudio Zucca

Dr. Claudio Zucca

Clinical Neurophysiology Unit, IRCCS "Eugenio Medea", Bosisio Parini (LC), Italy
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MBMaria Clara Bonaglia
Maria Clara Bonaglia
RGRoberto Giorda
Roberto Giorda
SBSilvana Beri
Silvana Beri
CACristina De Agostini
Cristina De Agostini
FNFrancesca Novara
Francesca Novara
OZorsetta zuffardi
orsetta zuffardi
In this study, we used deletions at 22q13, which represent a substantial source of human pathology (Phelan/McDermid syndrome), as a model for investigating the molecular mechanisms of terminal deletions that are currently poorly understood. We characterized at the molecular level the genomic rearrangement in 44 unrelated patients with 22q13 monosomy resulting from simple terminal deletions (72%), ring chromosomes (14%), and unbalanced translocations (7%). We also discovered interstitial deletions between 17–74 kb in 9% of the patients. Haploinsufficiency of the SHANK3 gene, confirmed in all rearrangements, is very likely the cause of the major neurological features associated with PMS. SHANK3 mutations can also result in language and/or social interaction disabilities. We determined the breakpoint junctions in 29 cases, providing a realistic snapshot of the variety of mechanisms driving non-recurrent deletion and repair at chromosome ends. De novo telomere synthesis and telomere capture are used to repair terminal deletions; non-homologous end-joining or microhomology-mediated break-induced replication is probably involved in ring 22 formation and translocations; non-homologous end-joining and fork stalling and template switching prevail in cases with interstitial 22q13.3. For the first time, we also demonstrated that distinct stabilizing events of the same terminal deletion can occur in different early embryonic cells, proving that terminal deletions can be repaired by multistep healing events and supporting the recent hypothesis that rare pathogenic germline rearrangements may have mitotic origin. Finally, the progressive clinical deterioration observed throughout the longitudinal medical history of three subjects over forty years supports the hypothesis of a role for SHANK3 haploinsufficiency in neurological deterioration, in addition to its involvement in the neurobehavioral phenotype of PMS. Terminal chromosome deletions are among the most commonly observed rearrangements detected by cytogenetics and may result in several well-known genetic syndromes. We used 22q13 deletions to study how these types of chromosome abnormalities arise. Children with Phelan/McDermid syndrome, caused by deletion of the terminal portion of chromosome 22, experience developmental delay, absent or severely delayed speech, and frequent behavioral problems. Lack of one copy of SHANK3, a key gene for the correct development and organization of brain synapses, is very likely the basis of the syndrome's major neurological features. Deletion of additional genes probably causes more complex phenotypes in subjects with larger deletions. We also studied patients who only lack a portion of SHANK3 and demonstrated that small, hard-to-detect deletions of this gene may cause substantial clinical problems. Until now, the 22q distal deletion had been only diagnosed in very young people. We studied a large group of patients of different ages and discovered that all adult patients face progressive cognitive decline. Our study demonstrates that deletion of the terminal portion of chromosome 22, a prototype for terminal deletions in human chromosomes, can occur in several ways. Mosaic deletions of different size can also form in early embryogenesis.

13 July 2004 in Neurology
Verified
Journal Article
Closed access
PDF file
RBRenato Borgatti
Renato Borgatti
CZClaudio Zucca
Claudio Zucca
ACA. Cavallini
A. Cavallini
MFM. Ferrario
M. Ferrario
CPC. Panzeri
C. Panzeri
MBMaria Teresa Bassi
Maria Teresa Bassi
Background: Benign familial neonatal convulsion (BFNC) is a rare autosomal dominant disorder caused by mutations in two genes, KCNQ2 and KCNQ3, encoding for potassium channel subunits underlying the M-current. This current limits neuronal hyperexcitability by causing spike-frequency adaptation. Methods: The authors describe a BFNC family with four affected members: two of them exhibit BFNC only while the other two, in addition to BFNC, present either with a severe epileptic encephalopathy or with focal seizures and mental retardation. Results: All affected members of this family carry a novel missense mutation in the KCNQ2 gene (K526N), disrupting the tri-dimensional conformation of a C-terminal region of the channel subunit involved in accessory protein binding. When heterologously expressed in CHO cells, potassium channels containing mutant subunits in homomeric or heteromeric configuration with wild-type KCNQ2 and KCNQ3 subunits exhibit an altered voltage-dependence of activation, without changes in intracellular trafficking and plasma membrane expression. Conclusion: The KCNQ2 K526N mutation may affect M-channel function by disrupting the complex biochemical signaling involving KCNQ2 C-terminus. Genetic rather than acquired factors may be involved in the pathophysiology of the phenotypic variability of the neurologic symptoms associated with BFNC in the described family.

30 July 2004 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MBMaria Teresa Bassi
Maria Teresa Bassi
NBN Bresolin
N Bresolin
ATA Tonelli
A Tonelli
KNK Nazos
K Nazos
FCF Crippa
F Crippa
GCGiorgio Casari
Giorgio Casari
In most patients, the earliest manifestations clearly related to AHC are tonic–dystonic attacks and paroxysmal nystagmus associated with autonomic changes and paroxysmal dyspnoea and usually appear between 3 and 6 months of age. The hemiplegic episodes develop before 18 months of age lasting anywhere from minutes to days at a time and involving either side of the body or shifting from one side to the other during the same episode with a period of bilateral weakness when the second side becomes involved.3

1 August 2015
Verified
Conference Paper
Closed access
Stefania CoelliStefania Coelli
Stefania Coelli
RSRoberta Sclocco
Roberta Sclocco
RBRiccardo Barbieri
Riccardo Barbieri
GRGianluigi Reni
Gianluigi Reni
CZClaudio Zucca
Claudio Zucca
Anna Maria BianchiAnna Maria Bianchi
Anna Maria Bianchi
This paper investigates the relation between mental engagement level and sustained attention in 9 healthy adults performing a Conners' “not-X” continuous performance test (CPT), while their electroencephalographic (EEG) activity was simultaneously acquired. Spectral powers were estimated and extracted in the classical EEG frequency bands. The engagement index (β/α) was calculated employing four different cortical montages suggested by the literature. Results show the efficacy of the estimated measures in detecting changes in mental state and its correlation with subject reaction times throughout the test. Moreover, the influence of the recording sites was proved underling the role of frontal cortex in maintaining a constant sustained attention level.

1 September 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RGRoberto Giorda
Roberto Giorda
MBMaria Clara Bonaglia
Maria Clara Bonaglia
SBSilvana Beri
Silvana Beri
MFMarco Fichera
Marco Fichera
FNFrancesca Novara
Francesca Novara
OZorsetta zuffardi
orsetta zuffardi

1 September 1991 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ATA Tartara
A Tartara
CGCa Galimberti
Ca Galimberti
RMR Manni
R Manni
LPL Parietti
L Parietti
CZClaudio Zucca
Claudio Zucca
EAEt al
Et al